Matsui Ryota, Inaki Noriyuki, Tsuji Toshikatsu
Department of Gastroenterological Surgery, Ishikawa Prefectural Central Hospital, Kanazawa, Japan; Department of Surgery, Juntendo University Urayasu Hospital, Urayasu, Japan.
Department of Gastroenterological Surgery, Ishikawa Prefectural Central Hospital, Kanazawa, Japan; Department of Surgery, Juntendo University Urayasu Hospital, Urayasu, Japan; Department of Gastrointestinal Surgery/Breast Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
Nutrition. 2023 May;109:111958. doi: 10.1016/j.nut.2022.111958. Epub 2022 Dec 27.
The aim of the present study was to clarify the effect of malnutrition as defined by the Global Leadership Initiative on Malnutrition (GLIM) criteria on compliance with postoperative adjuvant chemotherapy and relapse-free survival (RFS) in patients with gastric cancer.
This single-center, retrospective cohort study included 281 consecutive patients with gastric cancer who underwent radical gastrectomy for pathologic stages II and III and received postoperative S-1 adjuvant chemotherapy between April 2008 and June 2018. Treatment failure was defined as discontinuation of adjuvant chemotherapy ≤1 y. Nutritional assessment was preoperatively performed according to the GLIM criteria for all patients. We analyzed risk factors for treatment failure and poor prognostic factors for RFS using multivariate analyses.
Treatment failure and recurrence were observed in 50 (17.8%) and 97 (34.5%) of the 281 patients, respectively. The median follow-up period was 52 mo. The treatment failure rate was higher (P = 0.032) and RFS was worse (P = 0.017) in the malnutrition group. In multivariate analyses, GLIM criteria-defined malnutrition was an independent risk factor for treatment failure (odds ratio = 3.110; 95% confidence interval [CI], 1.020-9.470; P = 0.046). Furthermore, severe malnutrition was an independent poor prognostic factor for RFS (hazard ratio = 1.767; 95% CI, 1.132-2.759; P = 0.012).
Preoperative malnutrition as defined by the GLIM criteria was an independent risk factor for poor compliance with adjuvant S-1 chemotherapy and a poor prognostic factor for RFS after radical gastrectomy in patients with advanced gastric cancer.
本研究旨在阐明全球营养不良领导倡议(GLIM)标准所定义的营养不良对胃癌患者术后辅助化疗依从性和无复发生存期(RFS)的影响。
这项单中心回顾性队列研究纳入了281例连续的胃癌患者,这些患者在2008年4月至2018年6月期间接受了针对病理分期为II期和III期的根治性胃切除术,并接受了术后S-1辅助化疗。治疗失败定义为辅助化疗中断≤1年。对所有患者术前按照GLIM标准进行营养评估。我们使用多因素分析来分析治疗失败的危险因素和RFS的不良预后因素。
281例患者中分别有50例(17.8%)和97例(34.5%)出现治疗失败和复发。中位随访期为52个月。营养不良组的治疗失败率更高(P = 0.032),RFS更差(P = 0.017)。在多因素分析中,GLIM标准定义的营养不良是治疗失败的独立危险因素(比值比 = 3.110;95%置信区间[CI],1.020 - 9.470;P = 0.046)。此外,严重营养不良是RFS的独立不良预后因素(风险比 = 1.767;95% CI,1.132 - 2.759;P = 0.012)。
GLIM标准定义的术前营养不良是晚期胃癌患者根治性胃切除术后辅助S-1化疗依从性差的独立危险因素和RFS的不良预后因素。